Advanced Solid Malignancies
Conditions
Interventions
None listed
Sponsors
National Cancer Center Hospital East
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Eligibility criteria are cases that meet all of the following 1.) to 3.) criteria to be considered eligible cases. 1,) Diagnosed with a solid malignancy. 2,) Be at least 20 years old. 3,) fall under a. or b. below. a. Cohort A (Retrospective cohort) Consent to the FoundationOne CDx Cancer Genome Profile at the National Cancer Institute East Hospital between June 2019 and February 2021, with insurance coverage. b. Cohort B (Prospective cohort) Consent to the FoundationOne CDx Cancer Genome Profile at the National Cancer Center East Hospital on or after March 2021, with written consent to participate in this study.
Exclusion criteria
Exclusion criteria: The exclusion criteria were cases that were deemed inappropriate for enrollment in this study by the attending physician.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.Agreement rate of evidence Level between the draft QA Commons report and EP 2.Agreement rate of drug reachability between the draft QA Commons report and EP 3.Agreement rate of Secondary Findings between the draft QA Commons report and EP | — |
Secondary
| Measure | Time frame |
|---|---|
| a.Association of cancer gene panel test results with clinicopathological factors and clinical course b.Differences in expert panel prep time with and without QA Commons c.Satisfaction of Annotators on Expert Panels | — |
Countries
Japan
Contacts
Public Contacttakao fujisawa
National Cancer Center Hospital East Head and neck medical oncology
Outcome results
None listed